Comment from Accredited Drug Testing

Summary: Accredited Drug Testing, a provider of drug and alcohol testing services, supports the proposal to exempt certain Class II clinical toxicology test system devices from premarket notification requirements. The company argues that the current 510(k) clearance process for reagents/assays hinders the certification of oral fluid testing for Federal purposes and advocates for SAMHSA to provide the sole oversight for these tests.